Table 1.
Maintenance of stemness using biophysical and biochemical stimulations.
Type of stimulation | Details of condition | Type of cells | Observation | Ref. |
---|---|---|---|---|
Biophysical stimulation | Low-intensity pulsed ultrasound (LIPUS) | hMSCs | hMSCs differentiated into chondrocyte without dedifferentiation in nonchondrogenic differentiation environments. | [18] |
LIPUS | hMSCs | The transplanted cells differentiated into chondrocytes and regenerated defect sites of recipient cartilage. | [19] | |
Ultrasound | hMSCs | Ultrasound treatment enhanced fracture healing by promoting osteogenic differentiation of hMSCs. | [20] | |
Fluid flow | Osteocyte, osteoblast, and hMSCs | Flow stimulation promoted recruitment, proliferation, and differentiation of osteoprogenitor cells. | [21] | |
| ||||
Overexpression of genetical factor | SRY- (sex-determining region Y-) box 2 (SOX2) Sirtuin 1 (SIRT1) |
hMSCs | Overexpression of Sox2 enhanced stemness of MSCs during in vitro cultivation. | [23] |
hMSC | Overexpression of SirT1 prevented age-associated senescence of MSCs via Sox2 regulation. | [26, 27] | ||
Octamer-binding transcription factor 4 (Oct4) or pron. nanOg (Nanog) | hMSC | Viral transfection of Oct4 or Nanog enhanced the self-renewal and differentiation potential of MSCs. | [24, 25] | |
| ||||
Treatment of organic compound | Resveratrol | hMSCs | Resveratrol treatment enhanced maintenance of the self-renewal and differentiation capacity of MSCs during ex vivo cultivation. | [28] |
Nuclear factor erythroid-derived 2-like 2 (NRF2) | hMSCs | Treatment of t-BHQ, the activator of NRF2, promoted self-renewal ability and osteogenic differentiation via inhibition of p53 expression. | [35] |